A neutralizing anti-YKL-40 antibody blocks tumor angiogenesis through binding to an arginine (R) and lysine (K)-rich functional domain of YKL-40
*Corresponding Author:
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
To read the full article Peer-reviewed Article PDF 
